Literature DB >> 1834549

Loss of activation-induced CD45RO with maintenance of CD45RA expression during prolonged culture of T cells and NK cells.

H S Warren1, L J Skipsey.   

Abstract

The results of the present study show that activation-induced changes in CD45RA and CD45RO expression on T cells and natural killer (NK) cells are not unidirectional for all cells during a 5-week culture period. T cells and NK cells were generated from a resting subpopulation of peripheral blood mononuclear cells (PBMC) defined by sedimentation at Percoll high buoyant densities (p greater than 1.0640 g/ml) and unresponsiveness to IL-2. T cells were activated by a combination of PHA, sheep erythrocytes and IL-2-conditioned medium (IL-2-CM), and NK cells were activated by co-culture with gamma-irradiated malignant melanoma (MM-170) cells and IL-2-CM. Both T-cell and NK-cell cultures were maintained by subculture in IL-2-CM. NK cells and the CD45R(Abright)RO(dim/neg) subpopulation of T cells gained CD45RO following activation and this was accompanied by a two-fold decrease in CD45RA expression. In different cultures, CD45RO expression was not stable on 28-80% of T cells and 10-55% of NK cells. Cells with decreased CD45RO expression showed increased expression of CD45RA. Instability of CD45RO expression on cultured T cells and NK cells occurred at a time following the period of rapid cell growth when the cells were entering a quiescent phase. Both the CD4+ and CD8+ T-cell subpopulation showed similar changes in CD45 isoform expression. In contrast to the results obtained with the CD45R(Abright)RO(dim/neg) resting T cells, the CD45RO(bright)RA(dim/neg) subpopulation of resting T cells when activated and cultured under identical conditions retained CD45RO expression and remained CD45RAdim/neg. Thus a significant proportion of resting CD45R(Abright)RO(dim/neg) T cells is not related in a differentiation sequence to resting CD45RObrightRAdim/neg T cells, and therefore resting CD45RAbrightROdim/neg T cells and resting NK cells may be heterogeneous with respect to their activation history.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1834549      PMCID: PMC1384675     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  21 in total

1.  Cyclic regulation of CD45 isoform expression in a long term human CD4+CD45RA+ T cell line.

Authors:  D M Rothstein; A Yamada; S F Schlossman; C Morimoto
Journal:  J Immunol       Date:  1991-02-15       Impact factor: 5.422

2.  Interconversion of CD45R subsets of CD4 T cells in vivo.

Authors:  E B Bell; S M Sparshott
Journal:  Nature       Date:  1990-11-08       Impact factor: 49.962

3.  Cellular events during memory T-cell activation in vitro: the UCHL1 (180,000 MW) determinant is newly synthesized after mitosis.

Authors:  A N Akbar; A Timms; G Janossy
Journal:  Immunology       Date:  1989-02       Impact factor: 7.397

4.  Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells.

Authors:  A N Akbar; L Terry; A Timms; P C Beverley; G Janossy
Journal:  J Immunol       Date:  1988-04-01       Impact factor: 5.422

5.  Limiting dilution analysis of proliferative responses in human lymphocyte populations defined by the monoclonal antibody UCHL1: implications for differential CD45 expression in T cell memory formation.

Authors:  M Merkenschlager; L Terry; R Edwards; P C Beverley
Journal:  Eur J Immunol       Date:  1988-11       Impact factor: 5.532

Review 6.  Differential expression of the leucocyte-common antigen family.

Authors:  M L Thomas; L Lefrançois
Journal:  Immunol Today       Date:  1988-10

7.  Transitions from high to low molecular weight isoforms of CD45 (T200) involve rapid activation of alternate mRNA splicing and slow turnover of surface CD45R.

Authors:  J P Deans; A W Boyd; L M Pilarski
Journal:  J Immunol       Date:  1989-08-15       Impact factor: 5.422

8.  Comparative studies of human FcRIII-positive and negative natural killer cells.

Authors:  A Nagler; L L Lanier; S Cwirla; J H Phillips
Journal:  J Immunol       Date:  1989-11-15       Impact factor: 5.422

9.  Human bone marrow allograft recipients: production of, and responsiveness to, interleukin 2.

Authors:  H S Warren; K Atkinson; R G Pembrey; J C Biggs
Journal:  J Immunol       Date:  1983-10       Impact factor: 5.422

10.  Lymphokine regulation of CD45R expression on human T cell clones.

Authors:  S A Brod; C E Rudd; M Purvee; D A Hafler
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

View more
  20 in total

Review 1.  Qualitative differences between naïve and memory T cells.

Authors:  Marion Berard; David F Tough
Journal:  Immunology       Date:  2002-06       Impact factor: 7.397

2.  Cytokine expression by high-density human lymphocytes.

Authors:  W A Sewell; M F Berger; L J Skipsey; M A Cooley; H S Warren
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

3.  In vivo estimates of division and death rates of human T lymphocytes.

Authors:  A R Mclean; C A Michie
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

4.  Chronic stimulation drives human NK cell dysfunction and epigenetic reprograming.

Authors:  Aimee Merino; Bin Zhang; Philip Dougherty; Xianghua Luo; Jinhua Wang; Bruce R Blazar; Jeffrey S Miller; Frank Cichocki
Journal:  J Clin Invest       Date:  2019-06-18       Impact factor: 14.808

5.  Co-expression of the CD45RA and CD45RO antigens on T lymphocytes in chronic arthritis.

Authors:  K L Summers; J L O'Donnell; D N Hart
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

6.  Activation of the immune system of cancer patients by continuous i.v. recombinant IL-2 (rIL-2) therapy is dependent on dose and schedule of rIL-2.

Authors:  J W Gratama; R J Bruin; C H Lamers; R Oosterom; E Braakman; G Stoter; R L Bolhuis
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

7.  Analysis of T cell subsets present in the peripheral blood and synovial fluid of reactive arthritis patients.

Authors:  H Beacock-Sharp; J L Young; J S Gaston
Journal:  Ann Rheum Dis       Date:  1998-02       Impact factor: 19.103

8.  Loss of naïve (CD45RA+) CD4+ lymphocytes during pediatric infection with feline immunodeficiency virus.

Authors:  Abigail D Carreño; Ayalew Mergia; Janelle Novak; Nazareth Gengozian; Calvin M Johnson
Journal:  Vet Immunol Immunopathol       Date:  2007-09-11       Impact factor: 2.046

9.  Immunohistological analysis of anti-melanoma host responses.

Authors:  R Strohal; K Marberger; H Pehamberger; G Stingl
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

10.  Pathological findings in human autoimmune lymphoproliferative syndrome.

Authors:  M S Lim; S E Straus; J K Dale; T A Fleisher; M Stetler-Stevenson; W Strober; M C Sneller; J M Puck; M J Lenardo; K S Elenitoba-Johnson; A Y Lin; M Raffeld; E S Jaffe
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.